小柯机器人

靶向淀粉样蛋白前体可减少后期阿尔茨海默氏样病理
2020-11-18 13:42

德国图宾根大学Mathias Jucker研究小组发现,在转基因小鼠中靶向淀粉样蛋白前体可减少后期阿尔茨海默氏样病理。相关论文于2020年11月16日在线发表于《自然—神经科学》。

在可检测到β-淀粉样蛋白(Aβ)沉积之前,研究人员在Aβ前体蛋白转基因小鼠中测试了各种抗体中和Aβ种子的能力。研究人员还使用了不同大小的小鼠和人脑来源的天然Aβ聚集体进行免疫沉淀来表征不同的抗体识别谱。在淀粉样前期急性给药后,至少一种抗体(aducanumab)导致6个月后Aβ沉积和下游病理的显著降低。这表明在脑中蛋白质聚集的滞后阶段已存在可治疗性靶向的致病性Aβ种子。
 
因此,阿尔茨海默氏病的临床前阶段(目前定义为无临床症状的Aβ沉积)可能是病原体种子形成和传播的较晚表现,目前尚无法在体内进行检测。
 
研究人员介绍,Aβ沉积是阿尔茨海默氏病中Aβ聚集相对较晚的结果。当致病性Aβ种子开始形成、繁殖和扩散时,还无法得知,也没有对其进行生化定义。
 
附:英文原文

Title: Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life

Author: Ruth E. Uhlmann, Christine Rother, Jay Rasmussen, Juliane Schelle, Carina Bergmann, Emily M. Ullrich Gavilanes, Sarah K. Fritschi, Anika Buehler, Frank Baumann, Angelos Skodras, Rawaa Al-Shaana, Natalie Beschorner, Lan Ye, Stephan A. Kaeser, Ulrike Obermller, Sren Christensen, Fredrik Kartberg, Jeffrey B. Stavenhagen, Jens-Ulrich Rahfeld, Holger Cynis, Fang Qian, Paul H. Weinreb, Thierry Bussiere, Lary C. Walker, Matthias Staufenbiel, Mathias Jucker

Issue&Volume: 2020-11-16

Abstract: Amyloid-β (Aβ) deposits are a relatively late consequence of Aβ aggregation in Alzheimer‘s disease. When pathogenic Aβ seeds begin to form, propagate and spread is not known, nor are they biochemically defined. We tested various antibodies for their ability to neutralize Aβ seeds before Aβ deposition becomes detectable in Aβ precursor protein-transgenic mice. We also characterized the different antibody recognition profiles using immunoprecipitation of size-fractionated, native, mouse and human brain-derived Aβ assemblies. At least one antibody, aducanumab, after acute administration at the pre-amyloid stage, led to a significant reduction of Aβ deposition and downstream pathologies 6 months later. This demonstrates that therapeutically targetable pathogenic Aβ seeds already exist during the lag phase of protein aggregation in the brain. Thus, the preclinical phase of Alzheimer‘s disease—currently defined as Aβ deposition without clinical symptoms—may be a relatively late manifestation of a much earlier pathogenic seed formation and propagation that currently escapes detection in vivo.

DOI: 10.1038/s41593-020-00737-w

Source: https://www.nature.com/articles/s41593-020-00737-w

Nature Neuroscience:《自然—神经科学》,创刊于1998年。隶属于施普林格·自然出版集团,最新IF:28.771
官方网址:https://www.nature.com/neuro/
投稿链接:https://mts-nn.nature.com/cgi-bin/main.plex


本期文章:《自然—神经科学》:Online/在线发表

分享到:

0